<Disease><Name>OCULOCEREBRORENAL SYNDROME OF LOWE</Name><Synonym>LOWE OCULOCEREBRORENAL SYNDROME</Synonym><OMIM><Number>309000</Number><URL>http://omim.org/entry/309000</URL></OMIM><Orphanet><Number>534</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=534</URL></Orphanet><Protein><Number>Inositol polyphosphate 5-phosphatase OCRL-1</Number><URL>http://www.uniprot.org/uniprot/Q01968</URL></Protein><ExPASy><Number>3.1.3.36</Number><URL>http://enzyme.expasy.org/EC/3.1.3.36</URL></ExPASy><Gene>Xq26.1</Gene><ICD>E72.0</ICD><Summary>rare ;X-linked recessive;mutation in the OCRL gene;cataract at birth, tubular manifestation 3-6 months</Summary><Symptoms><symtomp><id>2088</id><symptom>Amino acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3303</id><symptom>aminoaciduria</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2470</id><symptom>areflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3801</id><symptom>behavior, aggressive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2288</id><symptom>bone fractures / pathological fractures</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2219</id><symptom>buphthalmus</symptom><category>EYES</category></symtomp><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1983</id><symptom>constipation</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2221</id><symptom>cryptorchism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>2374</id><symptom>Fanconi syndrome</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2217</id><symptom>glaucoma</symptom><category>EYES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2468</id><symptom>impaired visual acuity</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2469</id><symptom>joint swelling</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2466</id><symptom>microphthalmus</symptom><category>EYES</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2554</id><symptom>onset, fetus / fetal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3629</id><symptom>proteinuria</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1995</id><symptom>rickets</symptom><category>ENDOCRINE SYSTEM | SKELATAL DEFECT</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>2150</id><name>alpha-Fetoprotein</name><specimen>plasma</specimen><value /><min>0.00</min><max>20.00</max><unit>mg/ml</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>2151</id><name>alpha-Fetoprotein</name><specimen>plasma</specimen><value /><min>0.00</min><max>6.00</max><unit>ng/ml</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1159</id><name>alpha-Fetoprotein</name><specimen>plasma</specimen><value /><min>0.00</min><max>18000.00</max><unit>ng/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1160</id><name>alpha-Fetoprotein</name><specimen>plasma</specimen><value /><min>0.00</min><max>28.00</max><unit>ng/ml</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>694</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>400.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>309</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>150.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>308</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>60.00</min><max>400.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>947</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>25.00</min><max>90.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>307</id><name>Lactate dehydrogenase (LDH)</name><specimen>serum</specimen><value>increased</value><min>110.00</min><max>210.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1115</id><name>Lactate dehydrogenase (LDH)</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>330.00</max><unit>U/l</unit><age>&gt; 10years</age><method /><comment /></metabolite><metabolite><id>405</id><name>Phosphate</name><specimen>serum</specimen><value>decreased</value><min>1.70</min><max>3.50</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>406</id><name>Phosphate</name><specimen>serum</specimen><value>decreased</value><min>1.40</min><max>3.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>407</id><name>Phosphate</name><specimen>serum</specimen><value>decreased</value><min>1.30</min><max>1.90</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>408</id><name>Phosphate</name><specimen>serum</specimen><value>decreased</value><min>0.60</min><max>1.50</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1038</id><name>Phosphate</name><specimen>serum</specimen><value>decreased</value><min>1.60</min><max>2.60</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>766</id><name>Protein, total</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>10.00</min><max>30.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1096</id><name>Protein</name><specimen>urine</specimen><value>increased</value><min>50.00</min><max>80.00</max><unit>mg/24 hr</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1035</id><name>Serum acid phosphatase</name><specimen>serum</specimen><value>increased</value><min>    </min><max>11.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6012</id><title>Kidney-differentiated cells derived from Lowe Syndrome patients iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex</title><author>Hsieh WC,</author><journal>PLoS One</journal><year>2018</year><book /><volume>13</volume><number>2</number><pages>e0192635</pages><co_aut>et al.</co_aut></literature><literature><id>6013</id><title>Lowe syndrome: A particularly severe phenotype without clinical kidney involvement</title><author>Abdalla E,</author><journal>Am J Med Genet A</journal><year>2018</year><book /><volume>176</volume><number>2</number><pages>460-464</pages><co_aut>et al.</co_aut></literature><literature><id>6578</id><title>OCRL Deficiency Impairs Endolysosomal Function in a Humanized Mouse Model for Lowe Syndrome and Dent Disease</title><author>Festa BP,</author><journal>Hum Mol Genet</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6584</id><title>Identification and functional analysis of a novel oculocerebrorenal syndrome of Lowe (OCRL) gene variant in two pedigrees with varying phenotypes including isolated congenital</title><author>Shalaby AK,</author><journal>Mol Vis</journal><year>2018</year><book /><volume>24</volume><number>0</number><pages>847-852</pages><co_aut>et al.</co_aut></literature><literature><id>6014</id><title>Loss of OCRL increases ciliary PI(4,5)P2 in Lowe oculocerebrorenal syndrome</title><author>Prosseda PP,</author><journal>J Cell Sci</journal><year>2017</year><book /><volume>130</volume><number>20</number><pages>3447-3454</pages><co_aut>et al.</co_aut></literature><literature><id>6015</id><title>The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2</title><author>De Matteis MA,</author><journal>Nat Rev Nephrol</journal><year>2017</year><book /><volume>13</volume><number>8</number><pages>455-470</pages><co_aut>et al.</co_aut></literature><literature><id>4871</id><title>The oculocerebrorenal syndrome of Lowe: an update</title><author>B&#246;kenkamp A,</author><journal>Pediatr Nephrol</journal><year>2016</year><book /><volume>31</volume><number>12</number><pages>2201-2212</pages><co_aut>Ludwig M</co_aut></literature><literature><id>4872</id><title>Lowe syndrome/Dent-2 disease: A comprehensive review of known and novel aspects</title><author>Recker F,</author><journal>J Pediatr Genet. 2013 Jun;2(2):53-68</journal><year>2013</year><book /><volume>2</volume><number>2</number><pages>53-68</pages><co_aut>Reutter H, Ludwig M</co_aut></literature><literature><id>4873</id><title>Lowe Syndrome</title><author>Lewis RA,</author><journal>GeneReviews&#174; [Internet]</journal><year>2012</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Nussbaum RL, Brewer ED</co_aut></literature><literature><id>6016</id><title>Renal Phenotype in Lowe Syndrome: A Selective Proximal Tubular Dysfunction</title><author>Bockenhauer D,</author><journal>Clin J Am Soc Nephrol</journal><year>2008</year><book /><volume>3</volume><number>5</number><pages>1430-1436</pages><co_aut>et al.</co_aut></literature><literature><id>2199</id><title>Lowe Syndrome Protein OCRL1 Interacts with Clathrin and Regulates Protein Trafficking between Endosomes and the Trans-Golgi Net</title><author>Choudhury R</author><journal>Mol Biol Cell</journal><year>2005</year><book /><volume>16</volume><number>8</number><pages>3467-3479</pages><co_aut>et al.</co_aut></literature><literature><id>2200</id><title>Glaucoma with the oculocerebrorenal syndrome of Lowe</title><author>Walton DS</author><journal>J Glaucoma</journal><year>2005</year><book /><volume>14</volume><number>3</number><pages>181-185</pages><co_aut>Katsavounidou G, Lowe CU</co_aut></literature><literature><id>2198</id><title>The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization</title><author>Suchy SF</author><journal>Am J Hum Genet</journal><year>2002</year><book /><volume>71</volume><number>6</number><pages>1420-1427</pages><co_aut>Nussbaum RL</co_aut></literature><literature><id>595</id><title>MR findings and neurologic manifestations in Lowe oculocerebrorenal syndrome</title><author>Ono J</author><journal>Pediatr Neurol</journal><year>1996</year><book /><volume>14</volume><number>0</number><pages>162-164</pages><co_aut>et al.</co_aut></literature><literature><id>123</id><title>The renal Fanconi syndrome</title><author>Bergeron M</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>3</volume><number>0</number><pages>3691-3704</pages><co_aut>et al.</co_aut></literature><literature><id>191</id><title>The oculocerebrorenal syndrome of Lowe (Lowe syndrome)</title><author>Charnas LR</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>3</volume><number>123</number><pages>3705-3716</pages><co_aut>Nussbaum RL</co_aut></literature><literature><id>597</id><title>Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus</title><author>Suchy SF</author><journal>Hum Mol Genet</journal><year>1995</year><book /><volume>4</volume><number>0</number><pages>2245-2250</pages><co_aut>Olivos-Glander IM, Nussabaum RL</co_aut></literature><literature><id>596</id><title>Organic aciduria, decreased renal ammonia production, hydrophthalmus, and mental retardation</title><author>Lowe CU</author><journal>Am J Dis Child</journal><year>1952</year><book /><volume>83</volume><number>0</number><pages>166-184</pages><co_aut>Terrey M, MacLachan EA</co_aut></literature></Literatures></Disease>